RE:Handling of the news release
They absolutely did release the results of the market study a couple weeks ago on the 1st. The news was just not enough to send the stock price soaring and certainly didn't push it into the .40s. It was also not enough to overshadow the FDA submission delay. The simple fact of the matter is that without FDA approval, this company is worth next to nothing. No amount of marketing spin is going to change that. They did a decent job with there quarterly report. The drops that we are seeing right now are totally justified IMO. Investors are not convinced that the new leadership can execute which is why the delay is having this effect on SP.